155 related articles for article (PubMed ID: 20169408)
1. New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.
Iida S; Ishida H; Tokumoto T; Omoto K; Shirakawa H; Shimizu T; Amano H; Setoguchi K; Nozaki T; Toki D; Tokita D; Tanabe K
Int Urol Nephrol; 2010 Dec; 42(4):935-45. PubMed ID: 20169408
[TBL] [Abstract][Full Text] [Related]
2. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
Sharif A; Moore RH; Baboolal K
Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
[TBL] [Abstract][Full Text] [Related]
3. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
5. New-onset diabetes after transplantation: drug-related risk factors.
Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
[TBL] [Abstract][Full Text] [Related]
6. The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant.
Singer J; Aouad LJ; Wyburn K; Gracey DM; Ying T; Chadban SJ
Transpl Int; 2022; 35():10078. PubMed ID: 35368638
[No Abstract] [Full Text] [Related]
7. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
Ramesh Prasad GV; Huang M; Bandukwala F; Nash MM; Rapi L; Montada-Atin T; Meliton G; Zaltzman JS
Clin Nephrol; 2009 Feb; 71(2):140-6. PubMed ID: 19203506
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation.
Tatar E; Kircelli F; Demirci MS; Turan MN; Gungor O; Asci G; Ozkahya M; Ok E; Hoscoskun C; Toz H
Int Urol Nephrol; 2013 Feb; 45(1):251-8. PubMed ID: 23054321
[TBL] [Abstract][Full Text] [Related]
9. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
Yates CJ; Fourlanos S; Colman PG; Cohney SJ
Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors of New-onset Diabetes After Renal Transplantation and Prognostic Analysis.
Wang Q; Wu J; Wang X; Huang Y; Li G; Ou T
Altern Ther Health Med; 2023 Mar; 29(2):230-235. PubMed ID: 36525355
[TBL] [Abstract][Full Text] [Related]
11. New-onset diabetes after transplantation--role of oral glucose tolerance test for diagnosis and study of risk factors.
Sahay M; Sahay RK; Narayan G;
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):897-902. PubMed ID: 24029252
[TBL] [Abstract][Full Text] [Related]
12. The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation.
Tokodai K; Amada N; Haga I; Takayama T; Nakamura A
Diabetes Res Clin Pract; 2014 Feb; 103(2):298-303. PubMed ID: 24468096
[TBL] [Abstract][Full Text] [Related]
13. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.
Maes BD; Kuypers D; Messiaen T; Evenepoel P; Mathieu C; Coosemans W; Pirenne J; Vanrenterghem YF
Transplantation; 2001 Nov; 72(10):1655-61. PubMed ID: 11726827
[TBL] [Abstract][Full Text] [Related]
14. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study.
Porrini E; Moreno JM; Osuna A; Benitez R; Lampreabe I; Diaz JM; Silva I; Domínguez R; Gonzalez-Cotorruelo J; Bayes B; Lauzurica R; Ibernon M; Moreso F; Delgado P; Torres A
Transplantation; 2008 Apr; 85(8):1133-8. PubMed ID: 18431233
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study.
Salah DM; Hafez M; Fadel FI; Selem YAS; Musa N
Pediatr Nephrol; 2023 Mar; 38(3):847-858. PubMed ID: 35816203
[TBL] [Abstract][Full Text] [Related]
16. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.
Shi D; Xie T; Deng J; Niu P; Wu W
Eur J Clin Pharmacol; 2018 Jun; 74(6):723-729. PubMed ID: 29546446
[TBL] [Abstract][Full Text] [Related]
17. Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?
Prasad N; Gurjer D; Bhadauria D; Gupta A; Srivastava A; Kaul A; Jaiswal A; Yadav B; Yadav S; Sharma RK
Nephrology (Carlton); 2014 Apr; 19(4):244-50. PubMed ID: 24447227
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation].
Allazova SS; Novikova MS; Kotenko ON; Shilov EM
Ter Arkh; 2020 Dec; 92(12):137-141. PubMed ID: 33720585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
